IP Five in 5 – Sandoz and Amgen Settle Patent Disputes, Activision Faces a $23.4 Million Patent Verdict and Adam Schiff Introduces Gen AI Bill to Protect Copyrighted Material
MaxVal’s IP Five in 5 (edition 11) covers top five IP news stories, including denosumab biosimilar dispute settlement, Activision patent verdict, and new US Bill protecting copyrighted material.